Women with ACS are less likely to be treated with guideline-directed medical therapies, less likely to undergo cardiac catheterization, and less likely to receive timely reperfusion.[6]

Men are more likely to report central chest pain, while women are more likely to report fatigue, dyspnea, indigestion, nausea/vomiting, palpitations and weakness[7], although some studies have found fewer differences in presentation[8]

Women are more likely to delay presentation. Additional factors associated with delay in seeking treatment include older age, Black or Hispanic race, and lower education and socioeconomic levels.[9]